PLUMP ANDREW STEWART (President, R&D) sold 17.7% of their position (165.39K shares) of TAKEDA PHARMACEUTICAL CO LTD on the open market
Open‑market sale worth $2.83M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/13/2026ACC: 0001493152-26-037507
DirectorOfficer· President, R&D
Since Mar 2026
-165.39K
Net shares
Net seller
$2.83M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
165.39K disposed
Non-Derivative Transactions1
American Depositary Shares
Direct
Shares
−165.39K
Price / share
$17.10
Trade value
$2.83M
% of position
17.7%
8/10/2026
931.96K→766.57K
Total
Net shares
−165.39K
Net value
-$2.83M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | 8/10/2026 | S · Sale | −165.39K | $17.10 | $2.83M | 17.7% | 931.96K | 766.57K |
| Total | −165.39K | -$2.83M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
American Depositary Shares
IndirectShares owned281.31K
Total
281.31K indirect281.31K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| American Depositary Shares | 281.31K | Indirect |
| Total | 281.31K | 281.31K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported